Reviewed by a GPhC-registered Pharmacist at Newdays Pharmacy | Published: 2026 | Book an appointment
| Quick Answer: Losing weight before surgery significantly reduces surgical risk, including anaesthetic complications, wound healing problems, and post operative infection. GLP-1 medications including Mounjaro and Wegovy are increasingly used to support pre-operative weight loss. However, most surgical teams recommend stopping GLP-1 medication before general anaesthesia due to the risk of delayed gastric emptying and aspiration. Always discuss with your surgical team and prescriber. |
Pre operative weight loss is one of the most impactful things a patient with obesity can do to reduce their surgical risk. At Newdays Pharmacy in Berkshire, patients seeking weight management before a planned surgical procedure are an increasingly recognised group, and GLP-1 medications have become an important tool in supporting rapid, clinically meaningful weight reduction before elective procedures.
Why Does Weight Loss Before Surgery Reduce Risk?
Obesity is independently associated with increased risk across multiple domains of surgical care:
- Anaesthetic risk: obesity affects airway management, increases the difficulty of intubation, and reduces functional residual capacity of the lungs, increasing desaturation risk
- Wound healing: adipose tissue is poorly vascularised, increasing infection risk and impairing healing at the surgical site
- Thrombotic risk: obesity is a significant independent risk factor for deep vein thrombosis and pulmonary embolism in the perioperative period
- Cardiovascular and respiratory complications: pre existing conditions related to obesity, including hypertension, obstructive sleep apnoea, and heart failure, increase the risk of major cardiac and pulmonary complications
- Joint and orthopaedic surgery: many orthopaedic surgeons set BMI thresholds for elective procedures such as knee or hip replacement because obesity reduces implant longevity and increases complication rates
How Much Weight Loss Makes a Difference?
Even modest weight loss of five to ten percent of body weight produces measurable improvements in blood pressure, blood glucose, respiratory function, and inflammatory markers that reduce surgical risk. For patients requiring weight loss to achieve a BMI threshold set by their surgical team, a structured programme using GLP-1 medication may enable achievement of the target within a clinically meaningful timeframe.
Stopping GLP-1 Medication Before Surgery: An Important Safety Consideration
GLP-1 receptor agonists, including semaglutide and tirzepatide, slow gastric emptying. There is increasing clinical evidence that delayed gastric emptying can persist for longer than the pharmacological half life of these medicines, potentially increasing the risk of aspiration of gastric contents during general anaesthesia even after standard pre operative fasting periods.
Most anaesthetic and surgical guidelines now recommend stopping GLP-1 medication one week before elective surgery requiring general anaesthesia. Some teams request a longer pause depending on the medicine and dose. The Royal College of Anaesthetists and the Association of Anaesthetists have issued guidance on this. Always discuss with your surgical team and ensure your pharmacist or prescriber is aware of your planned procedure.
It is important to emphasise that stopping the medication before surgery is a safety measure and does not negate the weight loss already achieved. Patients should resume their medication after surgery as directed by their prescriber.
| Book Now: Book a Travel Health Consultation or Weight Management Appointment: We serve patients from Windsor, Eton, Twyford, Reading, and across Berkshire and Buckinghamshire. |
Frequently Asked Questions
Yes. GLP-1 medicines such as Mounjaro and Wegovy are used to support weight loss before some orthopaedic procedures, including knee replacement surgery. A clinical assessment is needed to determine whether treatment is appropriate. You should also tell your surgical team that you are taking a GLP-1 medicine, as it will usually need to be stopped before your operation.
Current guidance recommends stopping GLP-1 receptor agonist injections at least one week before elective surgery involving general anaesthesia. Some hospitals or surgical teams may advise a longer break. Always follow the instructions provided by your surgeon, anaesthetist and prescribing clinician.
| Clinical Disclaimer: This article is intended for general information only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment or medication. Information is accurate as of the date of publication and reviewed by a GPhC-registered pharmacist. Newdays Pharmacy is registered with the General Pharmaceutical Council (GPhC). Branch registration numbers: Eton/Windsor 1029048 | Twyford 1028983 | Coley Park Reading 1029008. |